Karmanos Cancer Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Karmanos Cancer Institute brings 8 presentations to ASH 2026 in New Orleans. Its research centres on acute myeloid leukemia and other myeloid cancers. Posters cover FLT3-ITD length, menin inhibitor resistance and epigenetic age changes in GATA2- and DDX41-linked disease.
| Organization | ASH 2026 Attendance |
|---|---|
Karmanos Cancer Institute Detroit, MI | |
Comprehensive cancer center in Detroit, Michigan, providing cancer treatment and research, part of McLaren Health Care. | Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Session Mon Dec 14 4:30pm–5:45pm Multiple Myeloma: The Future is Now Multiple myeloma care today, covering T-cell redirecting therapy at early relapse, options after CAR-T failure, and maintenance for high-risk patients. Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Karmanos Cancer Institute
Tell us what you sell and we’ll find the people at Karmanos Cancer Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction